Locke Bio Partners with imaware to Bring Comprehensive Lab Testing to Telehealth

What You Should Know:

–  Locke Bio, a leading telehealth platform, has partnered with imaware, a premier lab-testing provider, to integrate comprehensive diagnostic testing into its digital healthcare ecosystem.

–  This collaboration removes one of the final barriers to fully remote healthcare, allowing telehealth providers to offer lab-validated treatments without requiring patients to visit a doctor’s office.

Locke Bio Expands Telehealth Capabilities with Lab Testing Integration

Locke Bio, a digital health platform enabling enterprises to launch compliant telehealth and online pharmacy solutions, has integrated lab testing into its services. This advancement allows enterprise clients to offer faster diagnoses and more precise treatment plans across all 50 states. Supported by a network of licensed doctors, pharmacies, and banks across the U.S. and Canada, Locke Bio provides a seamless digital healthcare experience.

Transforming Telehealth with Comprehensive Digital Care

Earlier this year, Locke Bio introduced Locke Bio Pay, a compliance-first payment solution developed in partnership with LegitScript. Used by over 80 companies to achieve compliance certification, it facilitates secure prescription transactions via Visa, Mastercard, and American Express. Now, with the integration of imaware’s lab testing services, Locke Bio further bridges the gap between digital and in-person healthcare, enabling patients to complete essential health assessments from home.

“By incorporating imaware’s lab testing, Locke Bio is redefining digital medicine,” said Cathy Tie, Founder & CEO of Locke Bio. “Patients can now receive a full spectrum of care remotely, including diagnostic insights that previously required in-person visits.”

Enhanced Patient Care Through Lab-Validated Diagnostics

Many prescription treatments, including hormone therapies and chronic disease management, require lab testing to ensure safety and efficacy. Through imaware’s network of CLIA/CAP-certified labs, Locke Bio’s telehealth providers can now deliver diagnostic certainty comparable to traditional clinics. This integration strengthens regulatory compliance while improving accessibility and convenience.

Key Benefits of the Integration:

• At-home convenience: Patients complete testing in under five minutes without clinic visits.
• Rapid insights: Providers receive fast, lab-validated results for precise treatment decisions.
• Improved accessibility: No scheduling hassles, reducing lost workdays and delays.
• Seamless compliance: Integrated regulatory adherence streamlines healthcare delivery.

A New Standard for Digital Healthcare

This partnership positions Locke Bio at the forefront of telehealth innovation, offering a fully integrated digital care experience. Enterprise clients can now provide end-to-end healthcare services, from patient onboarding and e-commerce to diagnostics and treatment, making remote healthcare as effective as in-person care.

The newly integrated lab testing services will be available to Locke Bio’s enterprise clients starting April 1, 2025. Companies interested in early integration can contact Locke Bio for seamless adoption.